Sarah Miksinski
Conseiller Juridique Général chez GILEAD SCIENCES, INC.
Profil
Sarah C.
Pope Miksinski is currently working as an Executive Director-CMC Regulatory Affairs at Gilead Sciences, Inc. and as a Director at International Society for Pharmaceutical Engineering.
She previously worked as a Senior Director-Global Regulatory Affairs at AstraZeneca PLC.
Postes actifs de Sarah Miksinski
| Sociétés | Poste | Début |
|---|---|---|
| GILEAD SCIENCES, INC. | Conseiller Juridique Général | - |
International Society for Pharmaceutical Engineering
 International Society for Pharmaceutical Engineering Miscellaneous Commercial ServicesCommercial Services The International Society for Pharmaceutical Engineering is a nonprofit association that focuses on scientific, technical, and regulatory advancement throughout the entire pharmaceutical lifecycle. The non-profit company is based in Tampa, FL. The company engages with all levels of regulators to ensure that their education, training, document development, and interpretation are cutting-edge and focused on enabling the production and supply of therapies and devices with unmatched levels of flow, efficiency, and quality sustainably and at scale. John Bournas has been the CEO of the company since 2015. | Directeur/Membre du Conseil | - |
Anciens postes connus de Sarah Miksinski
| Sociétés | Poste | Fin |
|---|---|---|
| ASTRAZENECA PLC | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| GILEAD SCIENCES, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
International Society for Pharmaceutical Engineering
International Society for Pharmaceutical Engineering Miscellaneous Commercial ServicesCommercial Services The International Society for Pharmaceutical Engineering is a nonprofit association that focuses on scientific, technical, and regulatory advancement throughout the entire pharmaceutical lifecycle. The non-profit company is based in Tampa, FL. The company engages with all levels of regulators to ensure that their education, training, document development, and interpretation are cutting-edge and focused on enabling the production and supply of therapies and devices with unmatched levels of flow, efficiency, and quality sustainably and at scale. John Bournas has been the CEO of the company since 2015. | Commercial Services |